OPTUMBeyond's analysis on OPTUM2026-08-11 — Optum study shows BLC and WLC have equivalent real-world costs in non-muscle-invasive bladder cancer care2026-08-11 — Optum study shows BLC and WLC have equivalent real-world costs for non-muscle-invasive bladder cancer, supporting adoption of blue light cystoscopy without financial penaltyBrowse the full archive →